Pneumococcal Capsular Polysaccharides Conjugated to Protein D for Prevention of Acute Otitis Media Caused by Both Streptococcus pneumoniae and Non-typable Haemophilus influenzae: A Randomised Double-Blind Efficacy Study

Published in The Lancet, this study assessed the efficacy of a novel vaccine that contained polysaccharides from 11 different Streptococcus pneumoniae serotypes each conjugated to Haemophilus influenzae-derived protein D in prevention of acute otitis media. ABSTRACT ONLY. (Learn how users in developing countries can gain free access to journal articles.)

Author(s): Prymula R, Peeters P, Chrobok V, et al.

Published: 2006

  • Visit web page (English)

    (Located at www.ncbi.nlm.nih.gov)

    Citation: Prymula R, Peeters P, Chrobok V, et al. Pneumococcal Capsular Polysaccharides Conjugated to Protein D for Prevention of Acute Otitis Media Caused by Both Streptococcus pneumoniae and Non-typable Haemophilus influenzae: A Randomised Double-blind Efficacy Study. Lancet. 2006;367(9512):740-748.

Resource types: Peer-reviewed journal

Diseases: Pneumococcus

Topics: Disease/vaccine specific information

Regions: Global